J Breast Cancer.  2009 Sep;12(3):210-214. 10.4048/jbc.2009.12.3.210.

Nationwide Survey of the Use of Absorbable Mesh in Breast Surgery in Korea

• Kim KS
• Park MY
• Kim WJ
• Na KY
• Jung YS
• Choi YJ
• Park YL
• Oh SJ
• Shin HJ
• Korean Breast Cancer Society

• KMID: 2242013
• DOI: http://doi.org/10.4048/jbc.2009.12.3.210

Abstract

The aim of this study is to investigate the use of absorbable mesh in breast surgery in Korea. We conducted a survey from members of Korea Breast Cancer Society by phone, E-mail, and notice on the website from 6th to 20th April 2009. A total of 54 breast surgeons had responded to the survey. Of these, 40 surgeons (74.1%) had used absorbable mesh during breast surgery, with Vicryl mesh(R) being the choice of every surgeon and Interceed(R) having been used by 36 (90%) of the surgeons. In responding to the indications for mesh use, 26 surgeons (65%) indicated that mesh use was effective when a deformity was expected regardless of T stage. Contraindications for mesh use principally included existing patients' comorbidity such as a wound healing problem, diabetes mellitus and immunocompromised condition. Thirty one surgeons (77.5%) had experienced an infection in the mesh insertion site. However, on a case basis, only 39 of 843 cases (4.6%) had resulted in an infection. In the follow up after mesh use, 33 of the 37 responding surgeons (89.2%) used breast ultrasonography. Nineteen of the 38 respondents (50%) replied that the mesh was absorbed in 6 months and it did not confuse diagnostic imaging. The cited merits of mesh included maintenance of breast shape following surgery (n=38/49, 77.6%) and ease of surgical use (n=35/49, 71.4%). However, the high price of mesh was cited as a disadvantage by 33 of the 48 respondents (68.8%). In summary, survey results mentioned above show that surgical mesh use in breast surgery is increasing by times and the procedures greatly varies by surgeons. Thereby, we suggest that a guideline for mesh use should be made in the near future.

Keyword

Breast; Surgery; Surgical mesh

MeSH Terms

Breast
Breast Neoplasms
Comorbidity
Congenital Abnormalities
Surveys and Questionnaires
Diabetes Mellitus
Diagnostic Imaging
Electronic Mail
Follow-Up Studies
Korea
Polyglactin 910
Surgical Mesh
Ultrasonography, Mammary
Wound Healing
Polyglactin 910

Figure

• 

  Figure 1 Indications of absorbable mesh.

• 

  Figure 2 Methods of application of absorbable mesh.

• 

  Figure 3 Duration of use of prophylactic antibiotics.

• 

  Figure 4 Infection time of absorbable mesh.

• 

  Figure 5 Follow up (FU) methods of absorbable mesh.

• 

  Figure 6 The advantage of absorbable mesh.

• 

  Figure 7 The disadvantage of absorbable mesh.

Reference

1. The Korean Breast Cancer Society. Nationwide Korean breast cancer data of 2004 using breast cancer registration program. J Breast Cancer. 2006. 9:151–161.

2. Ko SS. Korean Breast Cancer Society. Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update. J Surg Oncol. 2008. 98:318–323.

3. Fisher B, Bauer M, Margolese R, Poisson R, Redmond C, Fisher E. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985. 312:665–673.

4. Eom TI, Kim BS, Koo BY, Kim JW, Lim YA, Lee HH, et al. The use of a corrective procedure with vicryl mesh for oncoplastic surgery of the breast. J Breast Cancer. 2009. 12:36–40.

5. Clough KB, Lewis JS, Fitoussi A, Faucoult MC. Oncoplastic techniques allow extensive resection for breast-conserving therapy of breast carcinomas. Ann Surg. 2003. 237:26–34.

6. Ohuchi N, Harada Y, Ishida T. Breast conserving surgery for primary breast cancer: immediate volume replace using lateral tissue flap. Breast Cancer. 1997. 4:59–65.

7. Rietjens M, Urban CA, Rey PC, Mazzarol G, Maisonneuve P, Garusi C, et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast. 2007. 16:387–395.

8. Sanuki J, Fukuma E, Wadamori K, Higa K, Sakamoto N, Tsunoda Y. Volume replacement with polyglycolic acid mesh for correcting breast deformity after endoscopic conservative surgery. Clin Breast Cancer. 2005. 6:175.

9. Lee JH, Hong YI, Jeong JH, Lee JI, Lee JH, Moon HJ, et al. Volume replacement with polyglatin 910 mesh for breast reconstruction after endoscopy-assisted breast conserving surgery for treating early breast cancer: the early results. J Breast Cancer. 2009. 12:193–198.